Annals of the Rheumatic Diseases 2005;64:1474-1479
EXTENDED REPORT
Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögrens syndrome compared with non-Sjögrens sicca syndrome
1 Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, The Netherlands
2 Department of Dermatology/Allergology, University Medical Centre Utrecht, The Netherlands
Correspondence to:
Mr J M van Woerkom
Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, The Netherlands, PO Box 85500, 3508 GA Utrecht, The Netherlands; j.vanwoerkom{at}azu.nl
Objectives: To investigate whether differences in T helper (Th) 1 and Th2 cell activity in salivary glands ("local") or ("peripheral") blood can discriminate between Sjögrens syndrome (SS) and non-Sjögrens sicca syndrome (nSS-sicca). Additionally, to study relationships of local and peripheral Th cell activities with each other and with disease activity measures.
Methods: 62 sicca patients (32 with SS, 30 with nSS-sicca) were studied. Local Th1 (interferon
(IFN
)) and Th2 (interleukin (IL) 4) activity were determined using immunohistochemistry. T cell production of IFN
and IL4 in peripheral blood (PB) was determined by ELISA. Erythrocyte sedimentation rate (ESR) and serum IgG were considered disease activity measures.
Results: ESR and serum IgG were higher in patients with SS than in patients with nSS-sicca. Local Th1 cell activity was higher and PB Th1 activity lower in patients with SS than in those with nSS-sicca. Th2 cell activity did not differ significantly between the patient groups. The ratio IFN
/IL4 was higher in salivary glands and lower in PB in patients with SS than in patients with nSS-sicca. Local and peripheral Th1 and Th2 cell activities correlated with ESR and serum IgG levels. ESR, serum IgG, and local or peripheral Th1 or Th2 cell activity did not discriminate between patients with SS and nSS-sicca.
Conclusions: An imbalance between Th1 and Th2 activity in sicca patients is clearly related to the severity of disease, but cannot be used to distinguish between patients with SS and those with nSS-sicca.
Abbreviations: DMEM, Dulbeccos modified Eagles medium; ESR, erythrocyte sedimentation rate; IFN
, interferon
; IL, interleukin; nSS-sicca, non-Sjögrens sicca syndrome; PB, peripheral blood; PBS, phosphate buffered saline; pSS, primary Sjögrens syndrome; RA, rheumatoid arthritis; SG, salivary gland; SLE, systemic lupus erythematosus; SS, Sjögrens syndrome; sSS, secondary Sjögrens syndrome; Th, T helper
Keywords: Sjögrens syndrome; sicca syndrome; T helper cells; peripheral blood; salivary glands
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Lodde, B M, Baum, B J, Tak, P P, Illei, G
(2006). Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment. Ann Rheum Dis
65: 1406-1413
[Abstract] [Full Text] -
Hartgring, S A Y, Bijlsma, J W J, Lafeber, F P J G, van Roon, J A G
(2006). Interleukin-7 induced immunopathology in arthritis. Ann Rheum Dis
65: iii69-iii74
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
